Danrong Shi

1.7k total citations · 1 hit paper
22 papers, 1.0k citations indexed

About

Danrong Shi is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Danrong Shi has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Danrong Shi's work include SARS-CoV-2 and COVID-19 Research (9 papers), Liver physiology and pathology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Danrong Shi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), Liver physiology and pathology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Danrong Shi collaborates with scholars based in China, United States and United Kingdom. Danrong Shi's co-authors include Hangping Yao, Lanjuan Li, Nanping Wu, Tian-Hao Weng, Zhigang Wu, Linfang Cheng, Xiangyun Lu, Sai Li, Zheyuan Zhang and Jialu Xu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Cell Biology.

In The Last Decade

Danrong Shi

22 papers receiving 996 citations

Hit Papers

Molecular Architecture of the SARS-CoV-2 Virus 2020 2026 2022 2024 2020 200 400 600

Peers

Danrong Shi
Julia Peukes United Kingdom
Huan Ma China
Amrita Ojha United States
Suhua He China
Zeshi Li Netherlands
Danrong Shi
Citations per year, relative to Danrong Shi Danrong Shi (= 1×) peers Tian-Hao Weng

Countries citing papers authored by Danrong Shi

Since Specialization
Citations

This map shows the geographic impact of Danrong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danrong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danrong Shi more than expected).

Fields of papers citing papers by Danrong Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danrong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danrong Shi. The network helps show where Danrong Shi may publish in the future.

Co-authorship network of co-authors of Danrong Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Danrong Shi. A scholar is included among the top collaborators of Danrong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danrong Shi. Danrong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ming‐Hai, Qi Ma, Constantinos M. Mikelis, et al.. (2025). Humanized dual-targeting antibody–drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity. Acta Pharmacologica Sinica. 46(5). 1375–1389. 3 indexed citations
2.
Yang, Lin, Zhaoru Zhang, Penglei Jiang, et al.. (2024). Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia. Nature Cell Biology. 26(6). 946–961. 8 indexed citations
3.
Yang, Fan, Han‐Chung Wu, Ping Wang, et al.. (2024). Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus. Virus Research. 345. 199402–199402. 3 indexed citations
4.
Pan, Jingying, Danrong Shi, Xuebin Tian, et al.. (2024). Short-chain fatty acids play a key role in antibody response to SARS-CoV-2 infection in people living with HIV. Scientific Reports. 14(1). 31211–31211. 1 indexed citations
5.
Chen, Keda, Danrong Shi, Chaonan Li, et al.. (2023). Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice. Vaccines. 11(2). 429–429. 2 indexed citations
6.
Song, Yutong, Hangping Yao, Nanping Wu, et al.. (2023). In situ architecture and membrane fusion of SARS-CoV-2 Delta variant. Proceedings of the National Academy of Sciences. 120(18). e2213332120–e2213332120. 16 indexed citations
7.
Shi, Danrong, Chen Li, Miaojin Zhu, et al.. (2023). Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion. Bioactive Materials. 33. 1–13. 3 indexed citations
8.
Liang, L., Miaojin Zhu, Rui He, et al.. (2022). Development of a multi‐recombinase polymerase amplification assay for rapid identification of COVID‐19, influenza A and B. Journal of Medical Virology. 95(1). e28139–e28139. 15 indexed citations
9.
Zhu, Miaojin, Jia Ji, Danrong Shi, et al.. (2022). Unusual global outbreak of monkeypox: what should we do?. Frontiers of Medicine. 16(4). 507–517. 35 indexed citations
10.
Zhang, Jing, Xiamin Hu, Wan Hong, Tao Li, & Danrong Shi. (2022). Experimental research on mechanical properties and microstructure of magnesium phosphate cement-based high-strength concrete. Journal of Building Engineering. 65. 105784–105784. 13 indexed citations
11.
Shi, Danrong, Tian-Hao Weng, Jie Wu, et al.. (2021). Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study. Frontiers in Immunology. 12. 708184–708184. 24 indexed citations
12.
Chen, Shao‐Long, Guoping Wang, Danrong Shi, et al.. (2021). RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets. World Journal of Gastroenterology. 27(20). 2507–2520. 4 indexed citations
13.
Weng, Tian-Hao, Yan Dong, Danrong Shi, et al.. (2021). The MSP‐RON pathway regulates liver fibrosis through transforming growth factor beta‐dependent epithelial–mesenchymal transition. Liver International. 41(8). 1956–1968. 6 indexed citations
14.
Leong, Jiayu, Danrong Shi, Jeremy P. K. Tan, et al.. (2021). Potent Antiviral and Antimicrobial Polymers as Safe and Effective Disinfectants for the Prevention of Infections. Advanced Healthcare Materials. 11(9). e2101898–e2101898. 7 indexed citations
15.
Fang, Xueling, et al.. (2020). MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity. Frontiers in Immunology. 11. 569082–569082. 25 indexed citations
16.
Yao, Hangping, Yutong Song, Yong Chen, et al.. (2020). Molecular Architecture of the SARS-CoV-2 Virus. Cell. 183(3). 730–738.e13. 703 indexed citations breakdown →
17.
Liu, Yizhi, Danrong Shi, Bo Hong, et al.. (2020). Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer. World Journal of Gastrointestinal Oncology. 12(11). 1216–1236. 1 indexed citations
18.
Yao, Hangping, Xiangyun Lu, Qiong Chen, et al.. (2020). Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discovery. 6(1). 76–76. 73 indexed citations
19.
Yao, Hangping, Yutong Song, Yong Chen, et al.. (2020). Molecular Architecture of the SARS-CoV-2 Virus. SSRN Electronic Journal. 3 indexed citations
20.
Guo, Yanhe, et al.. (2015). Wishart RBM based DBN for polarimetric synthetic radar data classification. 1841–1844. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026